Back to search results

Enhanced Recovery After Surgery for Extremity Sarcoma

This study is looking at how well an Enhanced Recovery After Surgery (ERAS) program works for patients having surgery for sarcoma (a type of cancer) in their arms or legs. The ERAS program is a special plan designed to help you recover better after surgery, focusing on pain management without relying heavily on opioid medications. To join, you must be an adult (over 17) having surgery for a suspected extremity sarcoma at Vanderbilt University Medical Center. The study will measure success by looking at your pain levels and how well your limb functions after 3 months. The current status of this study is unclear, and it aims to enroll 120 participants.

Study design
This interventional study plans to enroll 120 adult participants. It is testing a specific procedure, the Enhanced Recovery After Surgery program.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for at least 3 months after surgery to assess pain and limb function.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04461171

Enhanced Recovery After Surgery in Extremity Sarcoma

Recruiting
NAAges 18+InterventionalTreatment
Joshua Lawrenz
~120 participants
Updated 2026-08-21 on ClinicalTrials.gov
What's tested:Enhanced Recovery After Surgery

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Pain scores
Measured over 3 months
+5 more outcomes measured

Conditions

Sarcoma

Explore related trials

Sarcoma

Where it's being run

1 sites across 1 states
Tennessee1

Study leadership

  • Joshua Lawrenz, MD · PRINCIPAL_INVESTIGATOR · Vanderbilt Medical Center

Who to contact

Vanderbilt-Ingram Service for Timely Access
[email protected]
800-811-8480
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Any patient at Vanderbilt University Medical Center treated with surgical excision of a suspected extremity sarcoma
Adult patients \>17 years of age
Patients of all preoperative opioid status (naïve or dependent)

Exclusion

Patients treated non-operatively
Non-English speaking patients

What this trial measures

  • Pain scores3 months

    Measured by Quality of Recovery questionnaire (QoR-15) scale = 0-10 (0=none of the time and 10 = all of the time)

  • Pain scores3 months

    Measured by Patient-Reported Outcomes Measurement Information System (PROMIS-29 Profile v2.0) Score 1-5 (1 being worst and 5 being best)

  • Limb function3 months

    Measured by Musculoskeletal Tumor Society scoring system (MSTS) scored from 0-5 (5 being best and 0 being worst)

  • Clinical outcomes - length of hospital stay3 months

    Measured by the number of days in the hospital

  • Clinical outcomes - opioid requirements3 months

    Measured by the amount of opioids consumed

  • Clinical outcomes - perioperative complications (e.g. wound complications and 30-day readmission)3 months

    Measured by the number of perioperative complications reported